Unterehmen auf Watchlist setzen
Enfusion
ISIN: US2928121043
WKN: A3C602
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Enfusion · ISIN: US2928121043 · Business Wire (ID: 20241119246594)
20 November 2024 10:15PM

Enfusion To Present at Upcoming Investor Events


Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:

  • Wells Fargo 8th Annual TMT Summit on Tuesday, December 3, 2024
  • UBS Global Technology and AI Conference on Wednesday, December 4, 2024

Live audio webcasts and archived replays of the events will be available in the Events & Presentations section of the Enfusion Investor Relations website at http://ir.enfusion.com.

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration boosting agility and powering growth. Enfusion partners with over 850 investment managers from 9 global offices spanning four continents.

Source: Enfusion, Inc.
Source Code: ENFN-IR

Contact

Investors
Bill Wright
investors@enfusion.com

Media
media@enfusion.com

Visuelle Wertentwicklung / Kursverlauf · Enfusion
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2024
BusinessWire
Kontakt:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422